Viewing Study NCT03540420


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-03-04 @ 12:01 PM
Study NCT ID: NCT03540420
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-15
First Post: 2018-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer
Sponsor: Norwegian University of Science and Technology
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-07-31
Start Date Type: ACTUAL
Primary Completion Date: 2024-04-01
Primary Completion Date Type: ACTUAL
Completion Date: 2027-04-01
Completion Date Type: ESTIMATED
First Submit Date: 2018-05-16
First Submit QC Date: None
Study First Post Date: 2018-05-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-07-12
Last Update Post Date: 2024-07-15
Last Update Post Date Type: ACTUAL